Insights
Notes from the finance seat.
Short, practical pieces on the questions biotech founders and boards actually ask. No trend pieces, no vendor roundups.
September 13, 2026
7 min read
What a Series A biotech should have in its books before the first audit
Your first audit is not a test of your science. It is a test of whether the finance function can produce support on demand. Here is what has to exist before fieldwork starts.
Read
September 13, 2026
6 min read
How to accrue CRO costs without surprising the board
Clinical spend is the largest line in a clinical stage P&L, and it arrives on invoices that lag the work by months. A contract map and a monthly conversation with clinical operations fix most of it.
Read
September 13, 2026
6 min read
Runway math when your milestone is a readout
Cash divided by burn tells you when the money runs out. It does not tell you whether you will have data in hand, and time to raise on it, before that happens. Those are the numbers that matter.
Read